Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma von Abou-Alfa, G.K., Qin, S., Ryoo, B.-Y., Lu, S.-N., Yen, C.-J., Feng, Y.-H., Lim, H.Y., Izzo, F., Colombo, M., Sarker, D., Bolondi, L., Vaccaro, G., Harris, W.P., Chen, Z., Hubner, R.A., Meyer, T., Sun, W., Harding, J.J., Hollywood, E.M., Ma, J., Wan, P.J., Ly, M., Bomalaski, J., Johnston, A., Lin, C.-C., Chao, Y., Chen, L.-T.

Volltext

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS–ESMO initiative endorsed... von Chen, L.-T., Martinelli, E., Cheng, A.-L., Pentheroudakis, G., Qin, S., Bhattacharyya, G.S., Ikeda, M., Lim, H.-Y., Ho, G.F., Choo, S.P., Ren, Z., Malhotra, H., Ueno, M., Ryoo, B.-Y., Kiang, T.C., Tai, D., Vogel, A., Cervantes, A., Lu, S.-N., Yen, C.-J., Huang, Y.-H., Chen, S.-C., Hsu, C., Shen, Y.-C., Tabernero, J., Yen, Y., Hsu, C.-H., Yoshino, T., Douillard, J.-Y.

Volltext

Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial von Chan, A.T.C., Lee, V.H.F., Hong, R.-L., Ahn, M.-J., Chong, W.Q., Kim, S.-B., Ho, G.F., Caguioa, P.B., Ngamphaiboon, N., Ho, C., Aziz, M.A.S.A., Ng, Q.S., Yen, C.-J., Soparattanapaisarn, N., Ngan, R.K.-C., Kho, S.K., Tiambeng, M.L.A., Yun, T., Sriuranpong, V., Algazi, A.P., Cheng, A., Massarelli, E., Swaby, R.F., Saraf, S., Yuan, J., Siu, L.L.

Volltext

The role of the VEGF-C VEGFR-3 axis in cancer progression von SU, J.-L, YEN, C.-J, CHEN, P.-S, CHUANG, S.-E, HONG, C.-C, KUO, I.-H, CHEN, H.-Y, HUNG, M.-C, KUO, M.-L

Volltext

A phase I study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies von Lin, C-C, Su, W-C, Yen, C-J, Hsu, C-H, Su, W-P, Yeh, K-H, Lu, Y-S, Cheng, A-L, Huang, D C-L, Fritsch, H, Voss, F, Taube, T, Yang, J C-H

Volltext

A phase I, open-label, multi-center, dose-escalation study of codrituzumab, an anti-glypican-3 monoclonal antibody, in combination with atezolizumab in patients with locally advanc... von Cheng, A.-L., Yen, C.-J., Okusaka, T., Ikeda, M., Hsu, C.-H., Wu, S.-Y., Morizane, C., Hashimoto, Y., Ueshima, K., Ohtomo, T., Tanaka, T., Kudo, M.

Volltext

Efficacy and safety of ramucirumab (RAM) in Asian and non-Asian patients with advanced hepatocellular carcinoma (HCC) and elevated alpha-fetoprotein (AFP): Subgroup analysis from t... von Kang, Y.-K., Kudo, M., Lim, H.-Y., Hsu, C.-H., Vogel, A., Brandi, G., Cheng, R., Carton, I., Abada, P., Hsu, Y., Zhu, A., Yen, C.-J.

Volltext

TCOG T1308 study: The final results of a phase II trial of modified gemcitabine plus S-1 combination as the first-line treatment in patients with advanced biliary tract cancer von Chiang, N.-J., Chen, L.-T., Chen, J.-S., Yang, S.-H., Hsu, C., Shan, Y.-S., Yen, C.-J., Chen, M.-H., Tsou, H.-H.

Volltext

Isatuximab plus atezolizumab in patients with advanced solid tumors: results from a phase I/II, open-label, multicenter study von Simonelli, M., Garralda, E., Eskens, F., Gil-Martin, M., Yen, C.-J., Obermannova, R., Chao, Y., Lonardi, S., Melichar, B., Moreno, V., Yu, M.-L., Bongiovanni, A., Calvo, E., Rottey, S., Machiels, J.-P., Gonzalez-Martin, A., Paz-Ares, L., Chang, C.-L., Mason, W., Lin, C.-C., Reardon, D.A., Vieito, M., Santoro, A., Meng, R., Abbadessa, G., Menas, F., Lee, H., Liu, Q., Combeau, C., Ternes, N., Ziti-Ljajic, S., Massard, C.

Volltext

Phase II trial of tepotinib vs sorafenib in Asian patients (pts) with advanced hepatocellular carcinoma (HCC) von Ryoo, B.-Y., Ren, Z., Kim, T.-Y., Pan, H., Rau, K.-M., Choi, H.J., Park, J.-W., Kim, J.H., Yen, C.-J., Kim, B.-H., Zhou, D., Straub, J., Zhao, C., Qin, S.

Volltext

KEYNOTE-412: Phase III study of pembrolizumab plus chemoradiation vs chemoradiation alone for locally advanced head and neck squamous cell carcinoma (HNSCC) von Machiels, J.-P., Licitra, L., Tao, Y.G., Yen, C.-J., Rischin, D., Waldron, J.N., Burtness, B.A., Gregoire, V., Agarwala, S.S., Yorio, J., Delord, J.-P., Aksoy, S., Ikeda, S., Hong, R.-L., Ge, J.Y., Brown, H., Bidadi, B., Siu, L.L.

Volltext

Phase II trial of tepotinib vs sorafenib for treatment-naïve advanced hepatocellular carcinoma (HCC) in Asian patients von Ryoo, B.-Y., Ren, Z., Kim, T.-Y., Pan, H., Rau, K.-M., Choi, H.J., Park, J.-W., Kim, J.H., Yen, C.-J., Kim, B.-H., Zhou, D., Straub, J., Zhao, C., Qin, S.

Volltext

Osteoprotegerin, inflammation and dyslipidemia are associated with abdominal aortic calcification in non-diabetic patients on peritoneal dialysis von Huang, J.-W, Lien, Y.-C, Yang, C.-Y, Liu, K.-L, Wu, C.-F, Yen, C.-J, Wu, C.-K, Lee, J.-K, Ho, S.-R, Wu, H.-Y, Chiang, C.-K, Cheng, H.-T, Shyu, R.-S, Hung, K.-Y

Volltext

Levels of homocysteine are inversely associated with cardiovascular fitness in women, but not in men: data from the National Health and Nutrition Examination Survey 1999–2002 von KUO, H.‐K., YEN, C.‐J., Bean, J. F.

Volltext

Linking C-Reactive Protein to Late-Life Disability in the National Health and Nutrition Examination Survey (NHANES) 1999–2002 von Kuo, Hsu-Ko, Bean, Jonathan F., Yen, Chung-Jen, Leveille, Suzanne G.

Volltext

A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer von Chen, J.S., Hsu, C., Chiang, N.J., Tsai, C.S., Tsou, H.H., Huang, S.F., Bai, L.Y., Chang, I.C., Shiah, H.S., Ho, C.L., Yen, C.J., Lee, K.D., Chiu, C.F., Rau, K.M., Yu, M.S., Yang, Y., Hsieh, R.K., Chang, J.Y., Shan, Y.S., Chao, Y., Chen, L.T., Shen, Wen-Chi, Hsu, Hung-Chih, Hsu, Chih-Hung, Shen, Ying-Chun, Wang, Tsang-En, Li, Chung-Pin, Chen, Ming-Huang, Kao, Wei-Yao, Chang, Ping-Ying, Wu, Cheng-Chung, Teng, Chien-Lin, Lu, Chang-Hsien, Lin, Shyh-Jer, Wang, Being-Whey, Chen, Yen-Yang, Chin, Yung-Hsin, Chung, Tsai-Rong, Yu, Wei-Lan, Lee, Mei-Hua, Lin, Ling-Fang, Lin, Pei-Chyi, Wu, Ya-Ling, Wang, Hui-Ling, Lu, Li-Ju, Chen, Shiang-Yi, Wu, Chih-Chu, Wei, Te-Chih

Volltext

Defunct brain stem cardiovascular regulation underlies cardiovascular collapse associated with methamphetamine intoxication von Li, Faith C H, Yen, J C, Chan, Samuel H H, Chang, Alice Y W

Volltext

Characteristics of air pressure fluctuations in high-rise drainage stacks von Cheng, C.L., Mui, K.W., Wong, L.T., Yen, C.J., He, K.C.

Volltext

A phase II study of weekly docetaxel and cisplatin plus oral tegafur uracil and leucovorin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer von Li, C-P, Chen, J-S, Chen, L-T, Yen, C-J, Lee, K-D, Su, W-P, Lin, P-C, Lu, C-H, Tsai, H-J, Chao, Y

Volltext

Genetic polymorphisms in the prostaglandin pathway genes and risk of head and neck cancer von Lee, W-T, Huang, C-C, Chen, K-C, Wong, T-Y, Ou, C-Y, Tsai, S-T, Yen, C-J, Fang, S-Y, Lo, H-I, Wu, Y-H, Hsueh, W-T, Yang, M-W, Lin, F-C, Hsiao, J-R, Huang, J-S, Chang, J-Y, Chang, K-Y, Wu, S-Y, Lin, C-L, Wang, Y-H, Weng, Y-L, Yang, H-C, Chang, JS

Volltext